Cargando…
Association of SARS-CoV-2 clades with clinical, inflammatory and virologic outcomes: An observational study
BACKGROUND: Host determinants of severe coronavirus disease 2019 include advanced age, comorbidities and male sex. Virologic factors may also be important in determining clinical outcome and transmission rates, but limited patient-level data is available. METHODS: We conducted an observational cohor...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8027908/ https://www.ncbi.nlm.nih.gov/pubmed/33840632 http://dx.doi.org/10.1016/j.ebiom.2021.103319 |
_version_ | 1783675888220504064 |
---|---|
author | Young, Barnaby E Wei, Wycliffe E Fong, Siew-Wai Mak, Tze-Minn Anderson, Danielle E Chan, Yi-Hao Pung, Rachael Heng, Cheryl SY Ang, Li Wei Zheng, Adrian Kang Eng Lee, Bernett Kalimuddin, Shirin Pada, Surinder Tambyah, Paul A Parthasarathy, Purnima Tan, Seow Yen Sun, Louisa Smith, Gavin JD Lin, Raymond Tzer Pin Leo, Yee-Sin Renia, Laurent Wang, Lin-Fa Ng, Lisa FP Maurer-Stroh, Sebastian Lye, David Chien Lee, Vernon J |
author_facet | Young, Barnaby E Wei, Wycliffe E Fong, Siew-Wai Mak, Tze-Minn Anderson, Danielle E Chan, Yi-Hao Pung, Rachael Heng, Cheryl SY Ang, Li Wei Zheng, Adrian Kang Eng Lee, Bernett Kalimuddin, Shirin Pada, Surinder Tambyah, Paul A Parthasarathy, Purnima Tan, Seow Yen Sun, Louisa Smith, Gavin JD Lin, Raymond Tzer Pin Leo, Yee-Sin Renia, Laurent Wang, Lin-Fa Ng, Lisa FP Maurer-Stroh, Sebastian Lye, David Chien Lee, Vernon J |
author_sort | Young, Barnaby E |
collection | PubMed |
description | BACKGROUND: Host determinants of severe coronavirus disease 2019 include advanced age, comorbidities and male sex. Virologic factors may also be important in determining clinical outcome and transmission rates, but limited patient-level data is available. METHODS: We conducted an observational cohort study at seven public hospitals in Singapore. Clinical and laboratory data were collected and compared between individuals infected with different SARS-CoV-2 clades. Firth's logistic regression was used to examine the association between SARS-CoV-2 clade and development of hypoxia, and quasi-Poisson regression to compare transmission rates. Plasma samples were tested for immune mediator levels and the kinetics of viral replication in cell culture were compared. FINDINGS: 319 patients with PCR-confirmed SARS-CoV-2 infection had clinical and virologic data available for analysis. 29 (9%) were infected with clade S, 90 (28%) with clade L/V, 96 (30%) with clade G (containing D614G variant), and 104 (33%) with other clades ‘O’ were assigned to lineage B.6. After adjusting for age and other covariates, infections with clade S (adjusted odds ratio (aOR) 0·030 (95% confidence intervals (CI): 0·0002–0·29)) or clade O (B·6) (aOR 0·26 (95% CI 0·064–0·93)) were associated with lower odds of developing hypoxia requiring supplemental oxygen compared with clade L/V. Patients infected with clade L/V had more pronounced systemic inflammation with higher concentrations of pro-inflammatory cytokines, chemokines and growth factors. No significant difference in the severity of clade G infections was observed (aOR 0·95 (95% CI: 0·35–2·52). Though viral loads were significantly higher, there was no evidence of increased transmissibility of clade G, and replicative fitness in cell culture was similar for all clades. INTERPRETATION: Infection with clades L/V was associated with increased severity and more systemic release of pro-inflammatory cytokines. Infection with clade G was not associated with changes in severity, and despite higher viral loads there was no evidence of increased transmissibility. |
format | Online Article Text |
id | pubmed-8027908 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-80279082021-04-08 Association of SARS-CoV-2 clades with clinical, inflammatory and virologic outcomes: An observational study Young, Barnaby E Wei, Wycliffe E Fong, Siew-Wai Mak, Tze-Minn Anderson, Danielle E Chan, Yi-Hao Pung, Rachael Heng, Cheryl SY Ang, Li Wei Zheng, Adrian Kang Eng Lee, Bernett Kalimuddin, Shirin Pada, Surinder Tambyah, Paul A Parthasarathy, Purnima Tan, Seow Yen Sun, Louisa Smith, Gavin JD Lin, Raymond Tzer Pin Leo, Yee-Sin Renia, Laurent Wang, Lin-Fa Ng, Lisa FP Maurer-Stroh, Sebastian Lye, David Chien Lee, Vernon J EBioMedicine Research Paper BACKGROUND: Host determinants of severe coronavirus disease 2019 include advanced age, comorbidities and male sex. Virologic factors may also be important in determining clinical outcome and transmission rates, but limited patient-level data is available. METHODS: We conducted an observational cohort study at seven public hospitals in Singapore. Clinical and laboratory data were collected and compared between individuals infected with different SARS-CoV-2 clades. Firth's logistic regression was used to examine the association between SARS-CoV-2 clade and development of hypoxia, and quasi-Poisson regression to compare transmission rates. Plasma samples were tested for immune mediator levels and the kinetics of viral replication in cell culture were compared. FINDINGS: 319 patients with PCR-confirmed SARS-CoV-2 infection had clinical and virologic data available for analysis. 29 (9%) were infected with clade S, 90 (28%) with clade L/V, 96 (30%) with clade G (containing D614G variant), and 104 (33%) with other clades ‘O’ were assigned to lineage B.6. After adjusting for age and other covariates, infections with clade S (adjusted odds ratio (aOR) 0·030 (95% confidence intervals (CI): 0·0002–0·29)) or clade O (B·6) (aOR 0·26 (95% CI 0·064–0·93)) were associated with lower odds of developing hypoxia requiring supplemental oxygen compared with clade L/V. Patients infected with clade L/V had more pronounced systemic inflammation with higher concentrations of pro-inflammatory cytokines, chemokines and growth factors. No significant difference in the severity of clade G infections was observed (aOR 0·95 (95% CI: 0·35–2·52). Though viral loads were significantly higher, there was no evidence of increased transmissibility of clade G, and replicative fitness in cell culture was similar for all clades. INTERPRETATION: Infection with clades L/V was associated with increased severity and more systemic release of pro-inflammatory cytokines. Infection with clade G was not associated with changes in severity, and despite higher viral loads there was no evidence of increased transmissibility. Elsevier 2021-04-08 /pmc/articles/PMC8027908/ /pubmed/33840632 http://dx.doi.org/10.1016/j.ebiom.2021.103319 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Research Paper Young, Barnaby E Wei, Wycliffe E Fong, Siew-Wai Mak, Tze-Minn Anderson, Danielle E Chan, Yi-Hao Pung, Rachael Heng, Cheryl SY Ang, Li Wei Zheng, Adrian Kang Eng Lee, Bernett Kalimuddin, Shirin Pada, Surinder Tambyah, Paul A Parthasarathy, Purnima Tan, Seow Yen Sun, Louisa Smith, Gavin JD Lin, Raymond Tzer Pin Leo, Yee-Sin Renia, Laurent Wang, Lin-Fa Ng, Lisa FP Maurer-Stroh, Sebastian Lye, David Chien Lee, Vernon J Association of SARS-CoV-2 clades with clinical, inflammatory and virologic outcomes: An observational study |
title | Association of SARS-CoV-2 clades with clinical, inflammatory and virologic outcomes: An observational study |
title_full | Association of SARS-CoV-2 clades with clinical, inflammatory and virologic outcomes: An observational study |
title_fullStr | Association of SARS-CoV-2 clades with clinical, inflammatory and virologic outcomes: An observational study |
title_full_unstemmed | Association of SARS-CoV-2 clades with clinical, inflammatory and virologic outcomes: An observational study |
title_short | Association of SARS-CoV-2 clades with clinical, inflammatory and virologic outcomes: An observational study |
title_sort | association of sars-cov-2 clades with clinical, inflammatory and virologic outcomes: an observational study |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8027908/ https://www.ncbi.nlm.nih.gov/pubmed/33840632 http://dx.doi.org/10.1016/j.ebiom.2021.103319 |
work_keys_str_mv | AT youngbarnabye associationofsarscov2cladeswithclinicalinflammatoryandvirologicoutcomesanobservationalstudy AT weiwycliffee associationofsarscov2cladeswithclinicalinflammatoryandvirologicoutcomesanobservationalstudy AT fongsiewwai associationofsarscov2cladeswithclinicalinflammatoryandvirologicoutcomesanobservationalstudy AT maktzeminn associationofsarscov2cladeswithclinicalinflammatoryandvirologicoutcomesanobservationalstudy AT andersondaniellee associationofsarscov2cladeswithclinicalinflammatoryandvirologicoutcomesanobservationalstudy AT chanyihao associationofsarscov2cladeswithclinicalinflammatoryandvirologicoutcomesanobservationalstudy AT pungrachael associationofsarscov2cladeswithclinicalinflammatoryandvirologicoutcomesanobservationalstudy AT hengcherylsy associationofsarscov2cladeswithclinicalinflammatoryandvirologicoutcomesanobservationalstudy AT angliwei associationofsarscov2cladeswithclinicalinflammatoryandvirologicoutcomesanobservationalstudy AT zhengadriankangeng associationofsarscov2cladeswithclinicalinflammatoryandvirologicoutcomesanobservationalstudy AT leebernett associationofsarscov2cladeswithclinicalinflammatoryandvirologicoutcomesanobservationalstudy AT kalimuddinshirin associationofsarscov2cladeswithclinicalinflammatoryandvirologicoutcomesanobservationalstudy AT padasurinder associationofsarscov2cladeswithclinicalinflammatoryandvirologicoutcomesanobservationalstudy AT tambyahpaula associationofsarscov2cladeswithclinicalinflammatoryandvirologicoutcomesanobservationalstudy AT parthasarathypurnima associationofsarscov2cladeswithclinicalinflammatoryandvirologicoutcomesanobservationalstudy AT tanseowyen associationofsarscov2cladeswithclinicalinflammatoryandvirologicoutcomesanobservationalstudy AT sunlouisa associationofsarscov2cladeswithclinicalinflammatoryandvirologicoutcomesanobservationalstudy AT smithgavinjd associationofsarscov2cladeswithclinicalinflammatoryandvirologicoutcomesanobservationalstudy AT linraymondtzerpin associationofsarscov2cladeswithclinicalinflammatoryandvirologicoutcomesanobservationalstudy AT leoyeesin associationofsarscov2cladeswithclinicalinflammatoryandvirologicoutcomesanobservationalstudy AT renialaurent associationofsarscov2cladeswithclinicalinflammatoryandvirologicoutcomesanobservationalstudy AT wanglinfa associationofsarscov2cladeswithclinicalinflammatoryandvirologicoutcomesanobservationalstudy AT nglisafp associationofsarscov2cladeswithclinicalinflammatoryandvirologicoutcomesanobservationalstudy AT maurerstrohsebastian associationofsarscov2cladeswithclinicalinflammatoryandvirologicoutcomesanobservationalstudy AT lyedavidchien associationofsarscov2cladeswithclinicalinflammatoryandvirologicoutcomesanobservationalstudy AT leevernonj associationofsarscov2cladeswithclinicalinflammatoryandvirologicoutcomesanobservationalstudy |